bta-$1.4 billion aus on tamiflu and relenza, page-3

Koro,

That is perhaps the most rediculous thing I have had the misfortune of reading on this forum.

That's saying plenty considering the crap mightybullsh&t dishes up on a regular basis.

How on earth did you draw the conclusion that todays SP is reflective of any details about the size of US order. Simply put we haven't received any, only US to spend $1billion on anti-virals.

Given the Enron and Halliburton debacales i think it would be a reasonable assumption that this order will be practically equally split amongst Roche and GSK.

Even if GSK only secure 20% it represents a massive windfall in royalties to BTA and that is the order for the US alone, what about the other major players in the global economy?